Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1995 1
1997 1
1998 1
2002 2
2003 2
2004 1
2005 3
2006 3
2007 11
2008 5
2009 4
2010 6
2011 4
2012 10
2013 6
2014 6
2015 3
2016 3
2017 4
2018 2
2019 2
2020 3
2021 6
2022 19
2023 12
2024 11
2025 29

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

144 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Barandoozi
Page 1
Trial of Anti-BDCA2 Antibody Litifilimab for Cutaneous Lupus Erythematosus.
Werth VP, Furie RA, Romero-Diaz J, Navarra S, Kalunian K, van Vollenhoven RF, Nyberg F, Kaffenberger BH, Sheikh SZ, Radunovic G, Huang X, Clark G, Carroll H, Naik H, Gaudreault F, Meyers A, Barbey C, Musselli C, Franchimont N; LILAC Trial Investigators. Werth VP, et al. N Engl J Med. 2022 Jul 28;387(4):321-331. doi: 10.1056/NEJMoa2118024. N Engl J Med. 2022. PMID: 35939578 Clinical Trial.
Trial of Anti-BDCA2 Antibody Litifilimab for Systemic Lupus Erythematosus.
Furie RA, van Vollenhoven RF, Kalunian K, Navarra S, Romero-Diaz J, Werth VP, Huang X, Clark G, Carroll H, Meyers A, Musselli C, Barbey C, Franchimont N; LILAC Trial Investigators. Furie RA, et al. N Engl J Med. 2022 Sep 8;387(10):894-904. doi: 10.1056/NEJMoa2118025. N Engl J Med. 2022. PMID: 36069871 Clinical Trial.
Effects of massage therapy on pain and anxiety intensity in patients with burns: A systematic review and meta-analysis.
Miri S, Hosseini SJ, Ghorbani Vajargah P, Firooz M, Takasi P, Mollaei A, Ramezani S, Tolouei M, Emami Zeydi A, Osuji J, Farzan R, Karkhah S. Miri S, et al. Int Wound J. 2023 Aug;20(6):2440-2458. doi: 10.1111/iwj.14089. Epub 2023 Jan 21. Int Wound J. 2023. Retraction in: Int Wound J. 2025 Mar;22(3):e70235. doi: 10.1111/iwj.70235. PMID: 36680488 Free PMC article. Retracted.
A comprehensive, systematic search was conducted in various international electronic databases, such as Scopus, PubMed, Web of Science, and Persian electronic databases such as Iranmedex, and Scientific Information Database using keywords extracted from Medical Subject Headings s …
A comprehensive, systematic search was conducted in various international electronic databases, such as Scopus, PubMed, Web of Science, and …
Olokizumab versus Placebo or Adalimumab in Rheumatoid Arthritis.
Smolen JS, Feist E, Fatenejad S, Grishin SA, Korneva EV, Nasonov EL, Samsonov MY, Fleischmann RM; CREDO2 Group. Smolen JS, et al. N Engl J Med. 2022 Aug 25;387(8):715-726. doi: 10.1056/NEJMoa2201302. N Engl J Med. 2022. PMID: 36001712 Clinical Trial.
Reducing cardiovascular risk with immunomodulators: a randomised active comparator trial among patients with rheumatoid arthritis.
Solomon DH, Giles JT, Liao KP, Ridker PM, Rist PM, Glynn RJ, Broderick R, Lu F, Murray MT, Vanni K, Santacroce LM, Abohashem S, Robson PM, Fayad Z, Mani V, Tawakol A, Bathon J; TARGET Trial Consortium. Solomon DH, et al. Ann Rheum Dis. 2023 Mar;82(3):324-330. doi: 10.1136/ard-2022-223302. Epub 2022 Nov 30. Ann Rheum Dis. 2023. PMID: 36450449 Free PMC article. Clinical Trial.
Updates on Tinea Incognita: Literature review.
Ghaderi A, Tamimi P, Firooz A, Fattahi M, Ghazanfari M, Fattahi M. Ghaderi A, et al. Curr Med Mycol. 2023 Jun;9(2):52-63. doi: 10.22034/cmm.2023.345069.1425. Curr Med Mycol. 2023. PMID: 38375520 Free PMC article. Review.
The Immunogenetics of Alopecia areata.
Rajabi F, Abdollahimajd F, Jabalameli N, Nassiri Kashani M, Firooz A. Rajabi F, et al. Adv Exp Med Biol. 2022;1367:19-59. doi: 10.1007/978-3-030-92616-8_2. Adv Exp Med Biol. 2022. PMID: 35286691
Alopecia areata (AA) is an autoimmune disease that targets the hair follicles (HF) and results in non-scarring hair loss. AA results from the collapse of the HF's immune privilege due to a combination of environmental and genetic factors that either change the local HF dyn …
Alopecia areata (AA) is an autoimmune disease that targets the hair follicles (HF) and results in non-scarring hair loss. AA results from th …
Nano-Sized Technologies for Miconazole Skin Delivery.
Firooz A, Namdar R, Nafisi S, Maibach HI. Firooz A, et al. Curr Pharm Biotechnol. 2016;17(6):524-31. doi: 10.2174/1389201017666160301102459. Curr Pharm Biotechnol. 2016. PMID: 26927217 Review.
Novel drug delivery strategies for improving econazole antifungal action.
Firooz A, Nafisi S, Maibach HI. Firooz A, et al. Int J Pharm. 2015 Nov 10;495(1):599-607. doi: 10.1016/j.ijpharm.2015.09.015. Epub 2015 Sep 14. Int J Pharm. 2015. PMID: 26383840 Review.
Treatment efficiency of antifungal drugs depends on their penetration through target layers of skin at effective concentrations. Econazole's poor water solubility limits its bioavailability and antifungal effects. Therefore, formulation strategies have been examined for de …
Treatment efficiency of antifungal drugs depends on their penetration through target layers of skin at effective concentrations. Econazole' …
144 results